| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/02/2005 | CN1191355C Process for preparing fowl paralysis virus using cntinuous avian cell line |
| 03/02/2005 | CN1191266C Compositions for treating inflammatory response |
| 03/02/2005 | CN1191264C Uridine derivatives as antibiotics |
| 03/02/2005 | CN1191263C 3-deoxy-desmycosin derivatives and process for their preparation |
| 03/02/2005 | CN1191262C Cranesbill total flavonoid extract and use in preparation of anti-virus medicine |
| 03/02/2005 | CN1191257C Carbamate and thiocarbamate podophyllotoxin derivatives, preparation method and pharmaceutical compositions containing them |
| 03/02/2005 | CN1191256C Hexahydrofuro[2,3-B] furan-3-yl-N-{3-(1,3-benzodioxo1-5-ylsulfonyl) (isobutyl) Aminol-1-benzyl-2-hydroxypropyl} carbamate as retroviral protease inhibitor |
| 03/02/2005 | CN1191255C Benzodiazepine derivatives as GABA A receptor modulators |
| 03/02/2005 | CN1191254C Fused pyrrole compounds, pharmaceutical composition containing the same, and the use thereof |
| 03/02/2005 | CN1191253C Crystal modification(of 8-cyano-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-[4.3.0] nonan-8-y1)-6 Fluoro-1,4-dinydro-4-oxo-3-quinoline carboxylic |
| 03/02/2005 | CN1191252C 3-position substituted quinolone derivativers and its use in pharmacy |
| 03/02/2005 | CN1191249C Quinoline and quinazoline compound for treating benign prostatic hyperplasia specially |
| 03/02/2005 | CN1191246C Indolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 03/02/2005 | CN1191245C Substitued cyclobutylamine derivatives |
| 03/02/2005 | CN1191244C Baicalein 8-position substituted methylamine like derivative and its preparation method |
| 03/02/2005 | CN1191243C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 03/02/2005 | CN1191242C Different crystalyzed (-)-6-chloro-4-cyclopropyl ethinyl-4-trifluoride-1, 4-dihydro-2H-3, 1-benzoxazine-2-ketone |
| 03/02/2005 | CN1191241C Pyridazinyl phenyl hydrazones useful against congestive heart failure |
| 03/02/2005 | CN1191240C Nitrogen monoxide synthase inhibitor, its preparation method and application |
| 03/02/2005 | CN1191239C Pyrazole derivatives for the treatment of viral diseases |
| 03/02/2005 | CN1191237C Substituted caprolactam carbonates and ethers and their use as anti-tumor agents |
| 03/02/2005 | CN1191236C Substituted 6,6-Hetero-dicycloderivative |
| 03/02/2005 | CN1191233C N-substituted nitrogen heterocyclic compound |
| 03/02/2005 | CN1191232C Aminomethylcarboxylic acid derivatives |
| 03/02/2005 | CN1191099C Medicine coated support frame of blood vessel |
| 03/02/2005 | CN1191093C DOS compounds an method for assaying the same |
| 03/02/2005 | CN1191090C Use of enterobaterium protein ompA associated with antigen for generating antiviral, aniparsitic or antitumoral cytotoxic response |
| 03/02/2005 | CN1191089C Use of an OmpA enterobacteriumprotein associated with the ELAGIGILTV peptide for treating melanomal |
| 03/02/2005 | CN1191078C External use ointment for treating burn and scald |
| 03/02/2005 | CN1191072C High-molecular medicine resisting tumor metastasis and its preparing process |
| 03/02/2005 | CN1191071C Product of ginsenoside mono compatibility for improving sextual function |
| 03/02/2005 | CN1191070C Osteoblast-specific mitogens and drugs contining such compounds |
| 03/02/2005 | CN1191069C Otic microbial combinations medicine |
| 03/02/2005 | CN1191068C Long-acting antiseptic injection for animal |
| 03/02/2005 | CN1191067C Lipid composition of high non-soluble platinum matches and lipid body |
| 03/02/2005 | CN1191066C Externally-used disinfector |
| 03/02/2005 | CN1191065C Application of toosendanin as inducer to make differentiation and wither of tumor cells |
| 03/02/2005 | CN1191064C Medicinal composition containing phenylacetylgluta-mine, phenylacetylisoglutamize, and/or their derivatices |
| 03/02/2005 | CN1191063C Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders |
| 03/02/2005 | CN1191062C Medicinal compositions |
| 03/02/2005 | CN1191061C Medical compositions |
| 03/02/2005 | CN1191060C Topical compositions for prostaglandin El delivery |
| 03/02/2005 | CN1191055C Cosmetic and/or pharmaceutical preparations |
| 03/02/2005 | CN1191018C Chewing gum component for eliminating nicotine |
| 03/02/2005 | CA2479613A1 Novel adamantane derivatives with neuroprotective, antidepressant and anti-ischaemic activities, and process for preparing them |
| 03/01/2005 | US6861561 Substituted aromatic policyclic tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 03/01/2005 | US6861558 Alzheimer's disease |
| 03/01/2005 | US6861553 Process for preparing nateglinide and intermediates thereof |
| 03/01/2005 | US6861532 Synthesis of 2-alkylcysteine |
| 03/01/2005 | US6861530 Piperidine derivatives |
| 03/01/2005 | US6861529 Cycloalkylpyrrole-3-carboxylic acid amide derivatives and heterocycloalkylpyrrole-3-carboxylic acid amide derivatives that bind with high affinity to the benzodiazepine site of GABA-A (gamma-aminobutyric acid) receptors |
| 03/01/2005 | US6861525 Reducing the corresponding glyoxylamide compound with phosphorus bormide or chloride |
| 03/01/2005 | US6861519 Soluble highly branched glucose polymers and their method of production |
| 03/01/2005 | US6861504 Treating thrombosis by administering a CD154 inhibitor, such as a metalloproteinase inhibitor |
| 03/01/2005 | US6861449 Method of treating neutrophil-related diseases with topical anesthetics |
| 03/01/2005 | US6861448 Nictoinamide adenine dinucleotide (NAD); microbiocides; antiseptics; plant safening agents; antibiotic resistance; agriculture; food treatment |
| 03/01/2005 | US6861447 Method for producing a coenzyme Q10/γ-cyclodextrin complex |
| 03/01/2005 | US6861446 C7 heterosubstituted acetate taxane compositions |
| 03/01/2005 | US6861443 Drugs; modulator of a nicotinic receptor antagonist |
| 03/01/2005 | US6861441 (4(4,9-diethoxy-1-oxo-1,3-dihydro-2H-benzo(f)isoindol-2-yl) phenyl)acetic acid |
| 03/01/2005 | US6861440 Antidiabetic agents |
| 03/01/2005 | US6861439 Treatment of cerebrovascular disease |
| 03/01/2005 | US6861438 7-oxo-4,7-dihydro-thieno(3,2-b)pyridine-6-carboxylic acid benzylamide derivatives; herpes viricides |
| 03/01/2005 | US6861437 Substituted imidazo [1,2-a] pyridine derivatives |
| 03/01/2005 | US6861436 Useful against multidrug resistant cancer cells |
| 03/01/2005 | US6861435 3-(amino-imino-methyl)benzyl derivatives with an amide -n-sulfonylamido on the methyl of the benzyl |
| 03/01/2005 | US6861431 Detoxification of cells, tissues |
| 03/01/2005 | US6861430 β-carboline derivatives and its pharmaceutical use against depression and anxiety |
| 03/01/2005 | US6861429 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors |
| 03/01/2005 | US6861428 Autoimmune disease; antiinflammatory agents; antiischemic agents; antiarthritic agents |
| 03/01/2005 | US6861426 Antiepileptic agents |
| 03/01/2005 | US6861425 Benzimidazole compounds as ORL1-receptor agonists |
| 03/01/2005 | US6861424 A piperazine compound as antithrombotic agent |
| 03/01/2005 | US6861421 Nociceptin analogs |
| 03/01/2005 | US6861420 N-substituted 1,2,4,5-tetrahydro-1H-benzo[d]azepine compounds |
| 03/01/2005 | US6861418 Modulating protein kinase signal transduction; anticancer agents |
| 03/01/2005 | US6861417 Such as 2-(4-fluorophenyl)-3-(pyridin-4-yl)pyrazine for treating cytokine mediated diseases such as psoriatic arthritis |
| 03/01/2005 | US6861415 Antagonize endogenous progesterone to induce menses or labor, treat endometriosis, dysmenorrhea; endocrine hormone-dependent tumors, and uterine fibroids, inhibit uterine endometrial proliferation and for contraception |
| 03/01/2005 | US6861414 Methods for enhancing graft survival by modulating heme oxygenase activity |
| 03/01/2005 | US6861412 Diphosphate salt of A 4″-substituted-9-deoxo-9A-AZA-9A-homoerythromycin derivative and its pharmaceutical composition |
| 03/01/2005 | US6861411 Method of treating eye infections with azithromycin |
| 03/01/2005 | US6861409 Compounds for use in the dtreatment of growth metabolic disorders |
| 03/01/2005 | US6861406 Use of peptides or small molecules in treatment of disease, in high-throughput screening, in use of metal-binding peptides derived from sequences present in CD74-homology domain of insulin-like growth factor |
| 03/01/2005 | US6861405 Administering to an animal a voltage-gated potassium channel Kv1.3 inhibiting amount of a Kv1.3 inhibitor to induce weight loss, decrease body fat, increase insulin sensitivity, decrease food intake and control appetite |
| 03/01/2005 | US6861404 Therapies for chronic renal failure |
| 03/01/2005 | US6861232 Creatinine biosensor |
| 03/01/2005 | US6861077 Use of plant extracts in a cosmetic composition to protect keratinous fibers |
| 03/01/2005 | US6861076 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| 03/01/2005 | US6861073 Dysfunctional satiety center syndrome and method of treatment therefor |
| 03/01/2005 | US6861072 Pharmaceutical composition with gastric residence and controlled release |
| 03/01/2005 | US6861071 Highly absorptive solid preparation |
| 03/01/2005 | US6861070 Medicinal compositions for treating evacuatory insufficiency |
| 03/01/2005 | US6861064 Encapsulation method |
| 03/01/2005 | US6861059 Administering DP-107 or a pharmaceutically acceptable derivative thereof along with at least one therapeutic agent; synergistic |
| 03/01/2005 | US6861056 Applying composition comprising interferon gamma antibodies topically to eye to treat hyperimmune reactions such as transplant rejection, uveitis, autoimmune diseases of eye |
| 03/01/2005 | US6861051 1,2-propylene glycol skin preparation solution and method of use thereof |
| 03/01/2005 | US6861049 Aqueous slurries useful for cleaning the tongue and throat |
| 03/01/2005 | US6861016 Apparatus and method for preparing microparticles |
| 03/01/2005 | US6860907 Method of particle formation |
| 03/01/2005 | CA2196174C Use of ketoconazole and related substances in medicaments for treatment of type ii diabetes |